EPICS Congress Coverage: ASCO GU 2021 Highlights

Expert perspectives and strategic insights on the latest therapeutic developments in genitourinary malignancies.

February 16, 2021
Daniel Petrylak, MD, Yale, Aptitude Health

FACULTY CHAIR

Daniel Petrylak, MD

Yale University, CT, US

FACULTY MEMBERS

Robert Dreicer, MD, MS, MACP, FASCO
University of Virginia Cancer Center, VA, US

Karim Fizazi, MD, PhD
Gustave Roussy Institute, Villejuif, France

Leonard Gomella, MD, FACS
Sidney Kimmel Cancer Center, PA, US

Thomas Powles, MD, MBBS, MRCP
Barts Cancer Institute, London, UK

Oliver Sartor, MD
Tulane Cancer Center, LA, US

Manuela Schmidinger, MD
Medical University of Vienna, Vienna, Austria

Susan Slovin, MD, PhD
Memorial Sloan Kettering Cancer Center, NY, US

Agenda

Export meeting topics

View Agenda

Sample Report

Start discovering the insights

View Report

KEY TAKEAWAYS AND STRATEGIC INSIGHTS

A report will be produced based on the meeting, and will discuss the following topics

  • Novel Therapies for BCG-Unresponsive NMIBC and MIBC
  • Novel Agents for Metastatic Bladder Cancers
  • Metastatic Prostate Cancer – Hormonal Therapies and Imaging
  • Cytotoxic, Immune, and Targeted Therapies for Metastatic Prostate Cancer
  • Advanced Renal Cell Carcinoma
  • Renal Cell Carcinoma – Subgroup-Specific Therapies

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.